Particulate, Specification Troubles Prompt Three Teva Recalls of Generic Tablets
Citing particulate and specification concerns, Teva is voluntarily recalling tens of thousands of bottles of generic hypertension drugs and five lots of generic oral contraceptives, the FDA says. The recalls are associated with three different products marketed by the Israeli-owned drugmaker’s U.S. subsidiary. Two were made at Teva plants, but one — metoprolol tartrate tablets USP 50 mg — was not, according to an enforcement report recently posted by the agency. The recall of the metoprolol tartrate tablets was initiated because some tablets did not conform to weight specifications, the report states. The 1,000-count bottles, each tagged with December 2013 expiration dates, were made by Emcure Pharmaceuticals at its Pune, India, plant. Drug Industry Daily
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!